ESR1 and breast carcinoma: As DDB2 appeared to be detected strongly in ER-positive breast cancer cell lines, we next examined the DDB2 mRNA level in breast cancer samples from 16 patients (eight positive and eight negative for ER expression) using semiquantitative RT-PCR.